NCT04777396: A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
- State
- Completed
- Phase
- Phase 3
- People
- 1,840 taking part
- Started
- 18 May 2021
- Primary completion
- 16 Sep 2025
- Arms
- Oral Semaglutide
- Results
- None posted
- 2 Mar 2021: Trial registered
- 18 May 2021: Trial started
- 30 Jan 2026: Trial completed